-
1
-
-
84885468626
-
Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report
-
Allen EN, Barnes KI, Mushi AM, Massawe I, Staedke SG, Mehta U, et al. Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report. Trials 2011;12(Suppl 1):A10.
-
(2011)
Trials
, vol.12
-
-
Allen, E.N.1
Barnes, K.I.2
Mushi, A.M.3
Massawe, I.4
Staedke, S.G.5
Mehta, U.6
-
2
-
-
33644906137
-
Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial
-
Bent S, Padula A, Avins AL. Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial. Annals of Internal Medicine 2006;144(4):257-61.
-
(2006)
Annals of Internal Medicine
, vol.144
, Issue.4
, pp. 257-261
-
-
Bent, S.1
Padula, A.2
Avins, A.L.3
-
3
-
-
33745890714
-
Management of safety information from clinical trials. Report of CIOMS Working Group VI
-
Geneva: CIOMS
-
Council for International Organizations of Medical Sciences. Management of safety information from clinical trials. Report of CIOMS Working Group VI. Management of safety information from clinical trials. Report of CIOMS Working Group VI. Geneva: CIOMS, 2005.
-
(2005)
Management of safety information from clinical trials. Report of CIOMS Working Group VI
-
-
-
5
-
-
77952197101
-
Reviewer guidance: Conducting a clinical sfatey review of a new product application and preparing a report on the review
-
US Food, Drug Administration. Reviewer guidance: Conducting a clinical sfatey review of a new product application and preparing a report on the review. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation /Guidances/ucm072974.pdf 2005.
-
(2005)
-
-
-
6
-
-
79957995000
-
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview
-
[PUBMED: 21559325]
-
Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Medicine 2011;8(5):e1001026. [PUBMED: 21559325]
-
(2011)
PLoS Medicine
, vol.8
, Issue.5
-
-
Golder, S.1
Loke, Y.K.2
Bland, M.3
-
8
-
-
80052145719
-
Checking reference lists to find additional studies for systematic reviews
-
Horsley T, Dingwall O, Sampson M. Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.MR000026.pub2]
-
(2011)
Cochrane Database of Systematic Reviews
, Issue.8
-
-
Horsley, T.1
Dingwall, O.2
Sampson, M.3
-
9
-
-
80053274373
-
Pitfalls in meta-analyses on adverse events reported form clinical trials
-
Huang HY, Andrews E, Jones J, Skoven ML, Tilson H. Pitfalls in meta-analyses on adverse events reported form clinical trials. Pharmacoepidemiology and Drug Safety 2011;20(10):1014-20.
-
(2011)
Pharmacoepidemiology and Drug Safety
, vol.20
, Issue.10
, pp. 1014-1020
-
-
Huang, H.Y.1
Andrews, E.2
Jones, J.3
Skoven, M.L.4
Tilson, H.5
-
10
-
-
0003663972
-
Guideline for Good Clinical Practice (Topic E6/R1)
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guideline for Good Clinical Practice (Topic E6/R1). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. 1996.
-
(1996)
-
-
-
11
-
-
85041796469
-
Pharmacovigilance planning: notice for guidance on planning pharmacovigilance activities (Topic E2E)
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Pharmacovigilance planning: notice for guidance on planning pharmacovigilance activities (Topic E2E). http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. 2004.
-
(2004)
-
-
-
12
-
-
8744229000
-
Better reporting of harms in randomized trials: an extension of the CONSORT statement
-
Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781-8.
-
(2004)
Annals of Internal Medicine
, vol.141
, Issue.10
, pp. 781-788
-
-
Ioannidis, J.P.1
Evans, S.J.2
Gøtzsche, P.C.3
O'Neill, R.T.4
Altman, D.G.5
Schulz, K.6
-
14
-
-
0034823867
-
Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
-
Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55.
-
(2001)
Journal of Clinical Epidemiology
, vol.54
, Issue.10
, pp. 1046-1055
-
-
Sterne, J.A.C.1
Egger, M.2
-
15
-
-
26944489067
-
Detecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods
-
Wernicke JF, Faries D, Milton D, Weyrauch K. Detecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methods. Drug Safety 2005;28(11):1057-63.
-
(2005)
Drug Safety
, vol.28
, Issue.11
, pp. 1057-1063
-
-
Wernicke, J.F.1
Faries, D.2
Milton, D.3
Weyrauch, K.4
|